Combined JAK inhibition and PD-1 immunotherapy for non–small cell lung cancer patientsDivij Mathew, Andy J. Minn, Darwin Ye et al.|Science|2024Cited by 205
Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancerDanish Memon, Matthew D. Hellmann, Adam J. Schoenfeld et al.|Cancer Cell|2024Cited by 177